Skip to main content
NCBI home page
Protein & Cell logoLink to Protein & Cell
. 2012 Mar 3;3(6):419–433. doi: 10.1007/s13238-012-2917-5

Minor fibrillar collagens, variable regions alternative splicing, intrinsic disorder, and tyrosine sulfation

Ming Fang 1,3, Reed Jacob 2,3, Owen McDougal 2,3, Julia Thom Oxford 1,3,✉
PMCID: PMC3484837  NIHMSID: NIHMS406957  PMID: 22752873

Abstract

Minor fibrillar collagen types V and XI, are those less abundant than the fibrillar collagen types I, II and III. The alpha chains share a high degree of similarity with respect to protein sequence in all domains except the variable region. Genomic variation and, in some cases, extensive alternative splicing contribute to the unique sequence characteristics of the variable region. While unique expression patterns in tissues exist, the functions and biological relevance of the variable regions have not been elucidated. In this review, we summarize the existing knowledge about expression patterns and biological functions of the collagen types V and XI alpha chains. Analysis of biochemical similarities among the peptides encoded by each exon of the variable region suggests the potential for a shared function. The alternative splicing, conservation of biochemical characteristics in light of low sequence conservation, and evidence for intrinsic disorder, suggest modulation of binding events between the surface of collagen fibrils and surrounding extracellular molecules as a shared function.

Electronic Supplementary Material

The online version of this article (doi:10.1007/s13238-012-2917-5 contains supplementary material, which is available to authorized users.

Keywords: minor fibrillar collagens, variable regions, alternative splicing, fibrillogenesis, heparan sulfate binding sites, intrinsic disorder, tyrosine sulfation

Electronic Supplementary Material

Supplementary Material(PDF 533 kb) (532.7KB, pdf)

Footnotes

Electronic Supplementary Material

The online version of this article (doi:10.1007/s13238-012-2917-5 contains supplementary material, which is available to authorized users.

References

  1. Andrikopoulos K., Liu X., Keene D.R., Jaenisch R., Ramirez F. Targeted mutation in the col5a2 gene reveals a regulatory role for type V collagen during matrix assembly. Nat Genet. 1995;9:31–36. doi: 10.1038/ng0195-31. [DOI] [PubMed] [Google Scholar]
  2. Andrikopoulos K., Suzuki H.R., Solursh M., Ramirez F. Localization of pro-alpha 2(V) collagen transcripts in the tissues of the developing mouse embryo. Dev Dyn. 1992;195:113–120. doi: 10.1002/aja.1001950205. [DOI] [PubMed] [Google Scholar]
  3. Annunen S., Körkkö J., Czarny M., Warman M.L., Brunner H.G., Kääriäinen H., Mulliken J.B., Tranebjaerg L., Brooks D.G., Cox G.F., et al. Splicing mutations of 54-bp exons in the COL11A1 gene cause Marshall syndrome, but other mutations cause overlapping Marshall/Stickler phenotypes. Am J Hum Genet. 1999;65:974–983. doi: 10.1086/302585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ben-Dov C., Hartmann B., Lundgren J., Valcárcel J. Genome-wide analysis of alternative pre-mRNA splicing. J Biol Chem. 2008;283:1229–1233. doi: 10.1074/jbc.R700033200. [DOI] [PubMed] [Google Scholar]
  5. Bi W., Deng J.M., Zhang Z., Behringer R.R., de Crombrugghe B. Sox9 is required for cartilage formation. Nat Genet. 1999;22:85–89. doi: 10.1038/8792. [DOI] [PubMed] [Google Scholar]
  6. Birk D.E. Type V collagen: heterotypic type I/V collagen interactions in the regulation of fibril assembly. Micron. 2001;32:223–237. doi: 10.1016/s0968-4328(00)00043-3. [DOI] [PubMed] [Google Scholar]
  7. Blaschke U.K., Eikenberry E.F., Hulmes D.J.S., Galla H.-J., Bruckner P. Collagen XI nucleates self-assembly and limits lateral growth of cartilage fibrils. J Biol Chem. 2000;275:10370–10378. doi: 10.1074/jbc.275.14.10370. [DOI] [PubMed] [Google Scholar]
  8. Bowman K.G., Bertozzi C.R. Carbohydrate sulfotransferases: mediators of extracellular communication. Chem Biol. 1999;6:R9–R22. doi: 10.1016/S1074-5521(99)80014-3. [DOI] [PubMed] [Google Scholar]
  9. Bridgewater L.C., Lefebvre V., de Crombrugghe B. Chondrocyte-specific enhancer elements in the Col11a2 gene resemble the Col2a1 tissue-specific enhancer. J Biol Chem. 1998;273:14998–15006. doi: 10.1074/jbc.273.24.14998. [DOI] [PubMed] [Google Scholar]
  10. Chang W.C., Lee T.Y., Shien D.M., Hsu J.B., Horng J.T., Hsu P.C., Wang T.Y., Huang H.D., Pan R.L. Incorporating support vector machine for identifying protein tyrosine sulfation sites. J Comput Chem. 2009;30:2526–2537. doi: 10.1002/jcc.21258. [DOI] [PubMed] [Google Scholar]
  11. Chanut-Delalande H., Fichard A., Bernocco S., Garrone R., Hulmes D.J.S., Ruggiero F. Control of heterotypic fibril formation by collagen V is determined by chain stoichiometry. J Biol Chem. 2001;276:24352–24359. doi: 10.1074/jbc.m101182200. [DOI] [PubMed] [Google Scholar]
  12. Chen Y., Sumiyoshi H., Oxford J.T., Yoshioka H., Ramirez F., Morris N.P. Cis-acting elements regulate alternative splicing of exons 6A, 6B and 8 of the α1(XI) collagen gene and contribute to the regional diversification of collagen XI matrices. Matrix Biol. 2001;20:589–599. doi: 10.1016/s0945-053x(01)00169-x. [DOI] [PubMed] [Google Scholar]
  13. Davies S.R., Chang L.-W., Patra D., Xing X., Posey K., Hecht J., Stormo G.D., Sandell L.J. Computational identification and functional validation of regulatory motifs in cartilage-expressed genes. Genome Res. 2007;17:1438–1447. doi: 10.1101/gr.6224007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Erdman R., Stahl R.C., Rothblum K., Chernousov M.A., Carey D.J. Schwann cell adhesion to a novel heparan sulfate binding site in the N-terminal domain of alpha 4 type V collagen is mediated by syndecan-3. J Biol Chem. 2002;277:7619–7625. doi: 10.1074/jbc.M111311200. [DOI] [PubMed] [Google Scholar]
  15. Fabbri M., Garzon R., Cimmino A., Liu Z., Zanesi N., Callegari E., Liu S., Alder H., Costinean S., Fernandez-Cymering C., et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci U S A. 2007;104:15805–15810. doi: 10.1073/pnas.0707628104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Fernandes R.J., Weis M., Scott M.A., Seegmiller R.E., Eyre D.R. Collagen XI chain misassembly in cartilage of the chondrodysplasia (cho) mouse. Matrix Biol. 2007;26:597–603. doi: 10.1016/j.matbio.2007.06.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Fessler L.I., Brosh S., Chapin S., Fessler J.H. Tyrosine sulfation in precursors of collagen V. J Biol Chem. 1986;261:5034–5040. [PubMed] [Google Scholar]
  18. Fichard A., Kleman J.P., Ruggiero F. Another look at collagen V and XI molecules. Matrix Biol. 1995;14:515–531. doi: 10.1016/s0945-053x(05)80001-0. [DOI] [PubMed] [Google Scholar]
  19. Fischer H., Stenling R., Rubio C., Lindblom A. Colorectal carcinogenesis is associated with stromal expression of COL11A1 and COL5A2. Carcinogenesis. 2001;22:875–878. doi: 10.1093/carcin/22.6.875. [DOI] [PubMed] [Google Scholar]
  20. Fletcher R.B., Baker J.C., Harland R.M. FGF8 spliceforms mediate early mesoderm and posterior neural tissue formation in Xenopus. Development. 2006;133:1703–1714. doi: 10.1242/dev.02342. [DOI] [PubMed] [Google Scholar]
  21. Gregory K.E., Oxford J.T., Chen Y., Gambee J.E., Gygi S.P., Aebersold R., Neame P.J., Mechling D.E., Bächinger H.P., Morris N.P. Structural organization of distinct domains within the non-collagenous N-terminal region of collagen type XI. J Biol Chem. 2000;275:11498–11506. doi: 10.1074/jbc.275.15.11498. [DOI] [PubMed] [Google Scholar]
  22. Grimson A., Farh K.K.-H., Johnston W.K., Garrett-Engele P., Lim L.P., Bartel D.P. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell. 2007;27:91–105. doi: 10.1016/j.molcel.2007.06.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Guo Q., Li J.Y.H. Distinct functions of the major Fgf8 spliceform, Fgf8b, before and during mouse gastrulation. Development. 2007;134:2251–2260. doi: 10.1242/dev.004929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Halsted K.C., Bowen K.B., Bond L., Luman S.E., Jorcyk C.L., Fyffe W.E., Kronz J.D., Oxford J.T. Collagen α1(XI) in normal and malignant breast tissue. Mod Pathol. 2008;21:1246–1254. doi: 10.1038/modpathol.2008.129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Heller H., Schaefer M., Schulten K. Molecular dynamics simulation of a bilayer of 200 lipids in the gel and in the liquid-crystal phases. J Phys Chem. 1993;97:8343–8360. [Google Scholar]
  26. Holmes D.F., Kadler K.E. The 10+4 microfibril structure of thin cartilage fibrils. Proc Natl Acad Sci U S A. 2006;103:17249–17254. doi: 10.1073/pnas.0608417103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Huang S.C., Yu D.H., Wank S.A., Mantey S., Gardner J.D., Jensen R.T. Importance of sulfation of gastrin or cholecystokinin (CCK) on affinity for gastrin and CCK receptors. Peptides. 1989;10:785–789. doi: 10.1016/0196-9781(89)90114-9. [DOI] [PubMed] [Google Scholar]
  28. Imamura Y., Scott I.C., Greenspan D.S. The pro-alpha3(V) collagen chain. Complete primary structure, expression domains in adult and developing tissues, and comparison to the structures and expression domains of the other types V and XI procollagen chains. J Biol Chem. 2000;275:8749–8759. doi: 10.1074/jbc.275.12.8749. [DOI] [PubMed] [Google Scholar]
  29. Imhof M., Trueb B. Alternative splicing of the first F3 domain from chicken collagen XIV affects cell adhesion and heparin binding. J Biol Chem. 2001;276:9141–9148. doi: 10.1074/jbc.M009148200. [DOI] [PubMed] [Google Scholar]
  30. Kadler K.E., Baldock C., Bella J., Boot-Handford R.P. Collagens at a glance. J Cell Sci. 2007;120:1955–1958. doi: 10.1242/jcs.03453. [DOI] [PubMed] [Google Scholar]
  31. Kadler K.E., Hill A., Canty-Laird E.G. Collagen fibrillogenesis: fibronectin, integrins, and minor collagens as organizers and nucleators. Curr Opin Cell Biol. 2008;20:495–501. doi: 10.1016/j.ceb.2008.06.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Kahler R.A., Yingst S.M.C., Hoeppner L.H., Jensen E.D., Krawczak D., Oxford J.T., Westendorf J.J. Collagen 11a1 is indirectly activated by lymphocyte enhancer-binding factor 1 (Lef1) and negatively regulates osteoblast maturation. Matrix Biol. 2008;27:330–338. doi: 10.1016/j.matbio.2008.01.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Kato M., Zhang J., Wang M., Lanting L., Yuan H., Rossi J.J., Natarajan R. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-β-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci U S A. 2007;104:3432–3437. doi: 10.1073/pnas.0611192104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Kinoshita A., Greenwel P., Tanaka S., Di Liberto M., Yoshioka H., Ramirez F. A transcription activator with restricted tissue distribution regulates cell-specific expression of alpha1(XI) collagen. J Biol Chem. 1997;272:31777–31784. doi: 10.1074/jbc.272.50.31777. [DOI] [PubMed] [Google Scholar]
  35. Krek A., Grün D., Poy M.N., Wolf R., Rosenberg L., Epstein E.J., MacMenamin P., da Piedade I., Gunsalus K.C., Stoffel M., et al. Combinatorial microRNA target predictions. Nat Genet. 2005;37:495–500. doi: 10.1038/ng1536. [DOI] [PubMed] [Google Scholar]
  36. Ladd, A., and Cooper, T. (2002). Finding signals that regulate alternative splicing in the post-genomic era. Genome Biol 3, reviews0008.0001 reviews0008.0016. [DOI] [PMC free article] [PubMed]
  37. Lee S., Greenspan D.S. Transcriptional promoter of the human alpha 1(V) collagen gene (COL5A1) Biochem J. 1995;310:15–22. doi: 10.1042/bj3100015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Leitinger B., Hohenester E. Mammalian collagen receptors. Matrix Biol. 2007;26:146–155. doi: 10.1016/j.matbio.2006.10.007. [DOI] [PubMed] [Google Scholar]
  39. Leyte A., van Schijndel H.B., Niehrs C., Huttner W.B., Verbeet M.P., Mertens K., van Mourik J.A. Sulfation of Tyr1680 of human blood coagulation factor VIII is essential for the interaction of factor VIII with von Willebrand factor. J Biol Chem. 1991;266:740–746. [PubMed] [Google Scholar]
  40. Li S.-W., Takanosu M., Arita M., Bao Y., Ren Z.-X., Maier A., Prockop D.J., Mayne R. Targeted disruption of Col11a2 produces a mild cartilage phenotype in transgenic mice: comparison with the human disorder otospondylomegaepiphyseal dysplasia (OSMED) Dev Dyn. 2001;222:141–152. doi: 10.1002/dvdy.1178. [DOI] [PubMed] [Google Scholar]
  41. Li X.-Y., Mantovani R., Hooft van Huijsduijnen R., Andre I., Benoist C., Mathis D. Evolutionary variation of the CCAAT-binding transcription factor NF-Y. Nucleic Acids Res. 1992;20:1087–1091. doi: 10.1093/nar/20.5.1087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Li Y., Lacerda D.A., Warman M.L., Beier D.R., Yoshioka H., Ninomiya Y., Oxford J.T., Morris N.P., Andrikopoulos K., Ramirez F., et al. A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis. Cell. 1995;80:423–430. doi: 10.1016/0092-8674(95)90492-1. [DOI] [PubMed] [Google Scholar]
  43. Lincoln J., Florer J.B., Deutsch G.H., Wenstrup R.J., Yutzey K.E. ColVa1 and ColXIa1 are required for myocardial morphogenesis and heart valve development. Dev Dyn. 2006;235:3295–3305. doi: 10.1002/dvdy.20980. [DOI] [PubMed] [Google Scholar]
  44. Lincoln J., Florer J.B., Deutsch G.H., Wenstrup R.J., Yutzey K.E. ColVa1 and ColXIa1 are required for myocardial morphogenesis and heart valve development. Dev Dyn. 2006;235:3295–3305. doi: 10.1002/dvdy.20980. [DOI] [PubMed] [Google Scholar]
  45. Lincoln J., Kist R., Scherer G., Yutzey K.E. Sox9 is required for precursor cell expansion and extracellular matrix organization during mouse heart valve development. Dev Biol. 2007;305:120–132. doi: 10.1016/j.ydbio.2007.02.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Liu M.C., Lipmann F. Isolation of tyrosine-O-sulfate by Pronase hydrolysis from fibronectin secreted by Fujinami sarcoma virus-infected rat fibroblasts. Proc Natl Acad Sci U S A. 1985;82:34–37. doi: 10.1073/pnas.82.1.34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Lui V.C., Kong R.Y., Nicholls J., Cheung A.N., Cheah K.S. The mRNAs for the three chains of human collagen type XI are widely distributed but not necessarily co-expressed: implications for homotrimeric, heterotrimeric and heterotypic collagen molecules. Biochem J. 1995;311:511–516. doi: 10.1042/bj3110511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Lui V.C., Ng L.J., Sat E.W., Nicholls J., Cheah K.S. Extensive alternative splicing within the amino-propeptide coding domain of alpha2(XI) procollagen mRNAs. Expression of transcripts encoding truncated pro-alpha chains. J Biol Chem. 1996;271:16945–16951. doi: 10.1074/jbc.271.28.16945. [DOI] [PubMed] [Google Scholar]
  49. Luparello C., Sirchia R. Type V collagen regulates the expression of apoptotic and stress response genes by breast cancer cells. J Cell Physiol. 2005;202:411–421. doi: 10.1002/jcp.20131. [DOI] [PubMed] [Google Scholar]
  50. Makeyev E.V., Maniatis T. Multilevel regulation of gene expression by microRNAs. Science. 2008;319:1789–1790. doi: 10.1126/science.1152326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Marchant J.K., Hahn R.A., Linsenmayer T.F., Birk D.E. Reduction of type V collagen using a dominant-negative strategy alters the regulation of fibrillogenesis and results in the loss of corneal-specific fibril morphology. J Cell Biol. 1996;135:1415–1426. doi: 10.1083/jcb.135.5.1415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Matlin A.J., Clark F., Smith C.W.J. Understanding alternative splicing: towards a cellular code. Nat Rev Mol Cell Biol. 2005;6:386–398. doi: 10.1038/nrm1645. [DOI] [PubMed] [Google Scholar]
  53. Matsui Y., Chansky H.A., Barahmand-Pour F., Zielinska-Kwiatkowska A., Tsumaki N., Myoui A., Yoshikawa H., Yang L., Eyre D.R. COL11A2 collagen gene transcription is differentially regulated by EWS/ERG sarcoma fusion protein and wild-type ERG. J Biol Chem. 2003;278:11369–11375. doi: 10.1074/jbc.M300164200. [DOI] [PubMed] [Google Scholar]
  54. Matsuo N., Yu-Hua W., Sumiyoshi H., Sakata-Takatani K., Nagato H., Sakai K., Sakurai M., Yoshioka H. The transcription factor CCAAT-binding factor CBF/NF-Y regulates the proximal promoter activity in the human α1(XI) collagen gene (COL11A1) J Biol Chem. 2003;278:32763–32770. doi: 10.1074/jbc.M305599200. [DOI] [PubMed] [Google Scholar]
  55. Mayne R., Brewton R.G., Mayne P.M., Baker J.R. Isolation and characterization of the chains of type V/type XI collagen present in bovine vitreous. J Biol Chem. 1993;268:9381–9386. [PubMed] [Google Scholar]
  56. McAlinden A., Havlioglu N., Liang L., Davies S.R., Sandell L.J. Alternative splicing of type II procollagen exon 2 is regulated by the combination of a weak 5′ splice site and an adjacent intronic stem-loop cis element. J Biol Chem. 2005;280:32700–32711. doi: 10.1074/jbc.M505940200. [DOI] [PubMed] [Google Scholar]
  57. McAlinden A., Liang L., Mukudai Y., Imamura T., Sandell L.J. Nuclear protein TIA-1 regulates COL2A1 alternative splicing and interacts with precursor mRNA and genomic DNA. J Biol Chem. 2007;282:24444–24454. doi: 10.1074/jbc.M702717200. [DOI] [PubMed] [Google Scholar]
  58. McDougal, O.M., Mallory, C., Warner, L.R., and Oxford, J.T. (2011). Predicted structure and binding motifs of collagen α1(XI). J BioInformatics BioTech (In press). [PMC free article] [PubMed]
  59. McGuirt W.T., Prasad S.D., Griffith A.J., Kunst H.P.M., Green G.E., Shpargel K.B., Runge C., Huybrechts C., Mueller R.F., Lynch E., et al. Mutations in COL11A2 cause non-syndromic hearing loss (DFNA13) Nat Genet. 1999;23:413–419. doi: 10.1038/70516. [DOI] [PubMed] [Google Scholar]
  60. Medeck R.J., Sosa S., Morris N., Oxford J.T. BMP-1-mediated proteolytic processing of alternatively spliced isoforms of collagen type XI. Biochem J. 2003;376:361–368. doi: 10.1042/BJ20030894. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Melkoniemi M., Brunner H.G., Manouvrier S., Hennekam R., Superti-Furga A., Kääriäinen H., Pauli R.M., van Essen T., Warman M.L., Bonaventure J., et al. Autosomal recessive disorder otospondylomegaepiphyseal dysplasia is associated with loss-of-function mutations in the COL11A2 gene. Am J Hum Genet. 2000;66:368–377. doi: 10.1086/302750. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Michalickova K., Susic M., Willing M.C., Wenstrup R.J., Cole W.G. Mutations of the alpha2(V) chain of type V collagen impair matrix assembly and produce ehlers-danlos syndrome type I. Hum Mol Genet. 1998;7:249–255. doi: 10.1093/hmg/7.2.249. [DOI] [PubMed] [Google Scholar]
  63. Morris N.P., Oxford J.T., Davies G.B.M., Smoody B.F., Keene D.R. Developmentally regulated alternative splicing of the α1(XI) collagen chain: spatial and temporal segregation of isoforms in the cartilage of fetal rat long bones. J Histochem Cytochem. 2000;48:725–741. doi: 10.1177/002215540004800601. [DOI] [PubMed] [Google Scholar]
  64. Nagato H., Matsuo N., Sumiyoshi H., Sakata-Takatani K., Nasu M., Yoshioka H. The transcription factor CCAAT-binding factor CBF/NF-Y and two repressors regulate the core promoter of the human pro-α3(V) collagen gene (COL5A3) J Biol Chem. 2004;279:46373–46383. doi: 10.1074/jbc.M406069200. [DOI] [PubMed] [Google Scholar]
  65. Onnerfjord P., Heathfield T.F., Heinegård D. Identification of tyrosine sulfation in extracellular leucine-rich repeat proteins using mass spectrometry. J Biol Chem. 2004;279:26–33. doi: 10.1074/jbc.M308689200. [DOI] [PubMed] [Google Scholar]
  66. Oxford J.T., Doege K.J., Morris N.P. Alternative exon splicing within the amino-terminal nontriple-helical domain of the rat pro-α 1(XI) collagen chain generates multiple forms of the mRNA transcript which exhibit tissue-dependent variation. J Biol Chem. 1995;270:9478–9485. doi: 10.1074/jbc.270.16.9478. [DOI] [PubMed] [Google Scholar]
  67. Pankov R., Yamada K.M. Fibronectin at a glance. J Cell Sci. 2002;115:3861–3863. doi: 10.1242/jcs.00059. [DOI] [PubMed] [Google Scholar]
  68. Park S.-Y., Lee J.H., Ha M., Nam J.-W., Kim V.N. miR-29 miRNAs activate p53 by targeting p85α and CDC42. Nat Struct Mol Biol. 2009;16:23–29. doi: 10.1038/nsmb.1533. [DOI] [PubMed] [Google Scholar]
  69. Paul J.I., Hynes R.O. Multiple fibronectin subunits and their post-translational modifications. J Biol Chem. 1984;259:13477–13487. [PubMed] [Google Scholar]
  70. Pelisch F., Blaustein M., Kornblihtt A.R., Srebrow A. Cross-talk between signaling pathways regulates alternative splicing: a novel role for JNK. J Biol Chem. 2005;280:25461–25469. doi: 10.1074/jbc.M412007200. [DOI] [PubMed] [Google Scholar]
  71. Penkov D., Tanaka S., Di Rocco G., Berthelsen J., Blasi F., Ramirez F. Cooperative interactions between PBX, PREP, and HOX proteins modulate the activity of the alpha 2(V) collagen (COL5A2) promoter. J Biol Chem. 2000;275:16681–16689. doi: 10.1074/jbc.M909345199. [DOI] [PubMed] [Google Scholar]
  72. Pihlajamaa T., Prockop D.J., Faber J., Winterpacht A., Zabel B., Giedion A., Wiesbauer P., Spranger J., Ala-Kokko L. Heterozygous glycine substitution in the COL11A2 gene in the original patient with the Weissenbacher-Zweymüller syndrome demonstrates its identity with heterozygous OSMED (nonocular Stickler syndrome) Am J Med Genet. 1998;80:115–120. doi: 10.1002/(sici)1096-8628(19981102)80:2<115::aid-ajmg5>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  73. Pucci-Minafra I., Carella C., Cirincione R., Chimenti S., Minafra S., Luparello C. Type V collagen induces apoptosis of 8701-BC breast cancer cells and enhances m-calpain expression. Breast Cancer Res. 2000;2:E008. [Google Scholar]
  74. Ricard-Blum S., Ruggiero F. The collagen superfamily: from the extracellular matrix to the cell membrane. Pathol Biol (Paris) 2005;53:430–442. doi: 10.1016/j.patbio.2004.12.024. [DOI] [PubMed] [Google Scholar]
  75. Richards A.J., Martin S., Nicholls A.C., Harrison J.B., Pope F.M., Burrows N.P. A single base mutation in COL5A2 causes Ehlers-Danlos syndrome type II. J Med Genet. 1998;35:846–848. doi: 10.1136/jmg.35.10.846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Romero P., Obradovic Z., Li X., Garner E.C., Brown C.J., Dunker A.K. Sequence complexity of disordered protein. Proteins. 2001;42:38–48. doi: 10.1002/1097-0134(20010101)42:1<38::aid-prot50>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  77. Romero P.R., Zaidi S., Fang Y.Y., Uversky V.N., Radivojac P., Oldfield C.J., Cortese M.S., Sickmeier M., LeGall T., Obradovic Z., et al. Alternative splicing in concert with protein intrinsic disorder enables increased functional diversity in multicellular organisms. Proc Natl Acad Sci U S A. 2006;103:8390–8395. doi: 10.1073/pnas.0507916103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  78. Roulet M., Ruggiero F., Karsenty G., LeGuellec D. A comprehensive study of the spatial and temporal expression of the col5a1 gene in mouse embryos: a clue for understanding collagen V function in developing connective tissues. Cell Tissue Res. 2007;327:323–332. doi: 10.1007/s00441-006-0294-1. [DOI] [PubMed] [Google Scholar]
  79. Sakata-Takatani K., Matsuo N., Sumiyoshi H., Tsuda T., Yoshioka H. Identification of a functional CBF-binding CCAAT-like motif in the core promoter of the mouse pro-α 1(V) collagen gene (Col5a1) Matrix Biol. 2004;23:87–99. doi: 10.1016/j.matbio.2004.03.003. [DOI] [PubMed] [Google Scholar]
  80. Schwarze U., Atkinson M., Hoffman G.G., Greenspan D.S., Byers P.H. Null alleles of the COL5A1 gene of type V collagen are a cause of the classical forms of Ehlers-Danlos syndrome (types I and II) Am J Hum Genet. 2000;66:1757–1765. doi: 10.1086/302933. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Seibert C., Cadene M., Sanfiz A., Chait B. T., Sakmar T.P. Tyrosine sulfation of CCR5 N-terminal peptide by tyrosylprotein sulfotransferases 1 and 2 follows a discrete pattern and temporal sequence. Proc Natl Acad Sci USA. 2002;99:11031–11036. doi: 10.1073/pnas.172380899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Sengupta S., den Boon J.A., Chen I.H., Newton M.A., Stanhope S.A., Cheng Y.-J., Chen C.-J., Hildesheim A., Sugden B., Ahlquist P. MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. Proc Natl Acad Sci USA. 2008;105:5874–2000. doi: 10.1073/pnas.0801130105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Sirko-Osadsa D.A., Murray M.A., Scott J.A., Lavery M.A., Warman M.L., Robin N.H. Stickler syndrome without eye involvement is caused by mutations in COL11A2, the gene encoding the α2(XI) chain of type XI collagen. J Pediatr. 1998;132:368–371. doi: 10.1016/s0022-3476(98)70466-4. [DOI] [PubMed] [Google Scholar]
  84. Söderhäll C., Marenholz I., Kerscher T., Rüschendorf F., Esparza-Gordillo J., Worm M., Gruber C., Mayr G., Albrecht M., Rohde K., et al. Variants in a novel epidermal collagen gene (COL29A1) are associated with atopic dermatitis. PLoS Biol. 2007;5:e242. doi: 10.1371/journal.pbio.0050242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Srebrow A., Blaustein M., Kornblihtt A.R. Regulation of fibronectin alternative splicing by a basement membrane-like extracellular matrix. FEBS Lett. 2002;514:285–289. doi: 10.1016/s0014-5793(02)02382-7. [DOI] [PubMed] [Google Scholar]
  86. Stamm S., Ben-Ari S., Rafalska I., Tang Y., Zhang Z., Toiber D., Thanaraj T.A., Soreq H. Function of alternative splicing. Gene. 2005;344:1–20. doi: 10.1016/j.gene.2004.10.022. [DOI] [PubMed] [Google Scholar]
  87. Sugimoto M., Kimura T., Tsumaki N., Matsui Y., Nakata K., Kawahata H., Yasui N., Kitamura Y., Nomura S., Ochi T. Differential in situ expression of alpha2(XI) collagen mRNA isoforms in the developing mouse. Cell Tissue Res. 1998;292:325–332. doi: 10.1007/s004410051063. [DOI] [PubMed] [Google Scholar]
  88. Surmann-Schmitt C., Dietz U., Kireva T., Adam N., Park J., Tagariello A., Önnerfjord P., Heinegård D., Schlötzer-Schrehardt U., Deutzmann R., et al. Ucma, a novel secreted cartilage-specific protein with implications in osteogenesis. J Biol Chem. 2008;283:7082–7093. doi: 10.1074/jbc.M702792200. [DOI] [PubMed] [Google Scholar]
  89. Tanaka K., Tsumaki N., Kozak C.A., Matsumoto Y., Nakatani F., Iwamoto Y., Yamada Y. A Krüppel-associated box-zinc finger protein, NT2, represses cell-type-specific promoter activity of the α 2(XI) collagen gene. Mol Cell Biol. 2002;22:4256–4267. doi: 10.1128/MCB.22.12.4256-4267.2002. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  90. Tanaka S., Antoniv T.T., Liu K., Wang L., Wells D.J., Ramirez F., Bou-Gharios G. Cooperativity between far upstream enhancer and proximal promoter elements of the human α2(I) collagen (COL1A2) gene instructs tissue specificity in transgenic mice. J Biol Chem. 2004;279:56024–56031. doi: 10.1074/jbc.M411406200. [DOI] [PubMed] [Google Scholar]
  91. Tompson S.W., Bacino C.A., Safina N.P., Bober M.B., Proud V.K., Funari T., Wangler M.F., Nevarez L., Ala-Kokko L., Wilcox W.R., et al. Fibrochondrogenesis results from mutations in the COL11A1 type XI collagen gene. Am J Hum Genet. 2010;87:708–712. doi: 10.1016/j.ajhg.2010.10.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Tsumaki N., Kimura T. Differential expression of an acidic domain in the amino-terminal propeptide of mouse pro-alpha 2(XI) collagen by complex alternative splicing. J Biol Chem. 1995;270:2372–2378. doi: 10.1074/jbc.270.5.2372. [DOI] [PubMed] [Google Scholar]
  93. Tsumaki N., Kimura T., Matsui Y., Nakata K., Ochi T. Separable cis-regulatory elements that contribute to tissue- and site-specific alpha 2(XI) collagen gene expression in the embryonic mouse cartilage. J Cell Biol. 1996;134:1573–1582. doi: 10.1083/jcb.134.6.1573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Tsumaki N., Kimura T., Tanaka K., Kimura J.H., Ochi T., Yamada Y. Modular arrangement of cartilage- and neural tissue-specific cis-elements in the mouse alpha2(XI) collagen promoter. J Biol Chem. 1998;273:22861–22864. doi: 10.1074/jbc.273.36.22861. [DOI] [PubMed] [Google Scholar]
  95. Valcourt U., Gouttenoire J., Aubert-Foucher E., Herbage D., Mallein-Gerin F. Alternative splicing of type II procollagen pre-mRNA in chondrocytes is oppositely regulated by BMP-2 and TGF-beta1. FEBS Lett. 2003;545:115–119. doi: 10.1016/s0014-5793(03)00510-6. [DOI] [PubMed] [Google Scholar]
  96. Wahl M.C., Will C.L., Lührmann R. The spliceosome: design principles of a dynamic RNP machine. Cell. 2009;136:701–718. doi: 10.1016/j.cell.2009.02.009. [DOI] [PubMed] [Google Scholar]
  97. Warner L.R., Brown R.J., Yingst S.M.C., Oxford J.T. Isoform-specific heparan sulfate binding within the amino-terminal noncollagenous domain of collagen alpha1(XI) J Biol Chem. 2006;281:39507–39516. doi: 10.1074/jbc.M608551200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Wenstrup R.J., Florer J.B., Cole W.G., Willing M.C., Birk D.E. Reduced type I collagen utilization: a pathogenic mechanism in COL5A1 haplo-insufficient Ehlers-Danlos syndrome. J Cell Biochem. 2004;92:113–124. doi: 10.1002/jcb.20024. [DOI] [PubMed] [Google Scholar]
  99. Wenstrup R.J., Florer J.B., Willing M.C., Giunta C., Steinmann B., Young F., Susic M., Cole W.G. COL5A1 haploinsufficiency is a common molecular mechanism underlying the classical form of EDS. Am J Hum Genet. 2000;66:1766–1776. doi: 10.1086/302930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Xu L., Peng H., Wu D., Hu K., Goldring M.B., Olsen B.R., Li Y. Activation of the discoidin domain receptor 2 induces expression of matrix metalloproteinase 13 associated with osteoarthritis in mice. J Biol Chem. 2005;280:548–555. doi: 10.1074/jbc.M411036200. [DOI] [PubMed] [Google Scholar]
  101. Yamaguchi K., Matsuo N., Sumiyoshi H., Fujimoto N., Iyama K.-I., Yanagisawa S., Yoshioka H. Pro-α3(V) collagen chain is expressed in bone and its basic N-terminal peptide adheres to osteosarcoma cells. Matrix Biol. 2005;24:283–294. doi: 10.1016/j.matbio.2005.03.006. [DOI] [PubMed] [Google Scholar]
  102. Yoshioka H., Greenwel P., Inoguchi K., Truter S., Inagaki Y., Ninomiya Y., Ramirez F. Structural and functional analysis of the promoter of the human alpha 1(XI) collagen gene. J Biol Chem. 1995;270:418–424. doi: 10.1074/jbc.270.1.418. [DOI] [PubMed] [Google Scholar]
  103. Yoshioka H., Iyama K.-I., Inoguchi K., Khaleduzzaman M., Ninomiya Y., Ramirez F. Developmental pattern of expression of the mouse alpha 1 (XI) collagen gene (Col11a1) Dev Dyn. 1995;204:41–47. doi: 10.1002/aja.1002040106. [DOI] [PubMed] [Google Scholar]
  104. Zhang X., Boot-Handford R.P., Huxley-Jones J., Forse L.N., Mould A.P., Robertson D.L., Li L., Athiyal M., Sarras M.P., Jr. The Collagens of Hydra Provide Insight into the Evolution of Metazoan Extracellular Matrices. J Biol Chem. 2007;282:6792–6802. doi: 10.1074/jbc.M607528200. [DOI] [PubMed] [Google Scholar]
  105. Zhu Y., Oganesian A., Keene D.R., Sandell L.J. Type IIA procollagen containing the cysteine-rich amino propeptide is deposited in the extracellular matrix of prechondrogenic tissue and binds to TGF-beta1 and BMP-2. J Cell Biol. 1999;144:1069–1080. doi: 10.1083/jcb.144.5.1069. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Zoppi N., Gardella R., De Paepe A., Barlati S., Colombi M. Human fibroblasts with mutations in COL5A1 and COL3A1 genes do not organize collagens and fibronectin in the extracellular matrix, down-regulate α2β1 integrin, and recruit alphavbeta3 Instead of α5β1 integrin. J Biol Chem. 2004;279:18157–18168. doi: 10.1074/jbc.M312609200. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Material(PDF 533 kb) (532.7KB, pdf)

Articles from Protein & Cell are provided here courtesy of Oxford University Press

RESOURCES